10x Genomics (TXG)Samlyn Capital, LLC opened a new position $19.3M
Samlyn Capital, LLC opened a new position in 10x Genomics, per its Q2 2026 13F.
- 504K
- Shares reported
- 0.31%
- Disclosed portfolio weight
- $19.3M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 14, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 15, 2026Federal contract · $350K obligatedDepartment of Veterans Affairs awarded 10x Genomics, Inc.: $350K obligated to date
- Aug 4, 2026Federal contract · $134K obligatedDepartment of Agriculture awarded 10x Genomics, Inc.: $134K obligated to date
- Aug 5, 2026Federal contract · $127K obligatedDepartment of Agriculture awarded 10x Genomics, Inc.: $127K obligated to date
- Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- Aug 20, 2026Federal contract · $64K obligatedDepartment of Health and Human Services awarded 10x Genomics, Inc.: $64K obligated to date
- Aug 27, 2026Federal contract · $560K obligatedDepartment of Health and Human Services awarded 10x Genomics, Inc.: $560K obligated to date
- Sep 21, 2026Federal contract · $120K obligatedDepartment of Health and Human Services awarded 10x Genomics, Inc.: $120K obligated to date
- Sep 22, 2026Federal contract · $250K obligatedDepartment of Health and Human Services awarded 10x Genomics, Inc.: $250K obligated to date
- Sep 23, 2026Federal contract · $95K obligatedDepartment of Health and Human Services awarded 10x Genomics, Inc.: $95K obligated to date
- Sep 28, 2026Federal contract · $301K obligatedDepartment of Health and Human Services awarded 10x Genomics, Inc.: $301K obligated to date
- Sep 28, 2026Federal contract · $199K obligatedDepartment of Veterans Affairs awarded 10x Genomics, Inc.: $199K obligated to date
- Oct 7, 20265% stakeARK Investment Management LLC reported a passive stake (13G) of 5.2%
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for 10x Genomics
For 10x Genomics, OQRO holds 6 fund holdings reports (13F) and 9 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TXG page.
How this filing works
Other disclosures at 10x Genomics
- USAspending.gov award recordOct 5, 2026
- USAspending.gov award recordSep 28, 2026
- USAspending.gov award recordSep 23, 2026
- USAspending.gov award recordSep 22, 2026
- USAspending.gov award recordSep 21, 2026
- USAspending.gov award recordSep 9, 2026
Everything OQRO holds on this company is on its TXG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
